Enough Pitch Deck: All 16 Slides + Teardown

Slide 1: Title and Vision

The deck opens with a clear, minimalist title slide. The company name, Enough, is centered above the tagline 'delicious. nutritious. sustainable.' The slide immediately establishes the core theme of the pitch: 'Infrastructure & Scale.' By including a high-quality image of a prepared meal that looks like chicken, Enough signals that their biotech solution results in a familiar, appetizing food product. The date, August 2023, indicates this deck was used shortly before their reported 2024 Series B close.

Slide 3: Introduction & Overview

Slide 3 serves as a combined executive summary and team slide. It establishes the company's history, noting it was founded as '3F BIO' in 2015. The slide highlights a significant milestone: achieving production and revenue from the 'World’s largest new protein facility' in H1 2023. This is a critical piece of de-risking for a Series B round, moving the narrative from theoretical capacity to active operations. The team section is notable for its focus on industrial expertise; the inclusion of a former BP Global Petrochemicals CEO as Chair suggests the company views its challenge as a chemical engineering and logistics problem rather than just a culinary one. The slide also explicitly defines their B2B business model, aiming to be the 'lowest cost producer of protein.'

Slide 5: Addressing a Vast Market

Enough uses Slide 5 to frame the 'Problem' through the lens of market volume. They cite a global food protein market of 580+ million tonnes. Rather than focusing on a niche vegan segment, they target the entire protein industry. The slide includes a screenshot from The Sunday Times to provide social proof and cultural context for the 'dietary debate of our age.' The key metric here is the growth rate: +10 million tonnes per year, or 30,000 tonnes per day, emphasizing that the market is expanding faster than current sustainable solutions can keep up.

Slide 7: Market Estimates and Regional Focus

Slide 7 provides a more granular look at market demand, specifically within Europe. Using data from UBS and Euromonitor, the company projects a $4 billion increase in demand for plant-based proteins by 2027. The chart shows Western Europe as a primary growth driver ($4.0bn), which aligns with the company's HQ in Glasgow and their reported European operations. By using 'bearish' market estimates to still show a 'vast unmet need,' Enough builds credibility with skeptical investors who may be wary of hype in the alt-protein sector.

Slide 9: Mycoprotein - A Sustainable Protein

This slide introduces the product: ABUNDA mycoprotein. It describes the ingredient as a 'wet protein' with a consistency similar to chicken mince. The slide is effective because it shows the product in three stages: the raw ingredient, the B2B packaging (14kg bags), and the end-use applications (NO-Beef, NO-Tuna, NO-Chicken). This visual progression reinforces their B2B route-to-market strategy. They also list key product attributes: high in protein and fiber, containing all essential amino acids, and having a 'clean taste.'

Slide 11: Operational Plan

Slide 11 is the 'Scale' slide. It makes a bold claim: 'The largest non-animal protein factory globally.' The target of 60,000 tonnes per annum by 2027 is the centerpiece of their growth narrative. To make this number relatable, they provide a 'meat equivalent' comparison: 30 cows per hour. This type of comparison is highly effective in pitch decks as it translates abstract industrial metrics into a vivid, understandable scale of impact.

Slide 13: Impact

The Impact slide provides the ESG (Environmental, Social, and Governance) data that many modern institutional investors require. Enough compares ABUNDA against beef, chicken, peas, and lentils. The data is impressive: 93% less water than beef and 92% less CO2. By including comparisons to other sustainable options like peas and lentils (where they still claim a 15-24% advantage in CO2), they position mycoprotein as the superior choice among all alternatives, not just compared to animal meat. They also mention 'Rural development' and 'Job creation >200,' appealing to the social impact side of the investment.

Slide 15: Future Funding Plans

The final content slide, Slide 15, is surprisingly vague regarding the 'Ask.' It features a photo of the large team in front of their industrial facility, which reinforces the 'Infrastructure' theme. However, the text only states that growth will come from a 'combination of financing options.' There is no specific dollar amount listed on the slide, nor a breakdown of how the funds will be allocated. This suggests that this version of the deck may have been a general 'Business Overview' used for initial discussions rather than a final term-sheet pitch, or that the specific round details were kept in a separate, confidential document.

What Enough Does Well

Enough excels at positioning itself as an industrial powerhouse rather than a food startup. In a market where many companies struggle with the high costs of 'lab-grown' or niche plant-based products, Enough focuses entirely on the economics of scale. By citing their goal to be the 'lowest cost producer' (Slide 3) and showing their massive physical infrastructure (Slide 15), they address the biggest concern in the biotech space: margins. Their use of external data from reputable sources like UBS (Slide 7) adds a layer of professional rigor that is often missing from early-stage decks. Furthermore, their B2B focus is a strategic masterstroke; it allows them to avoid the massive marketing spend required to build a consumer brand, instead piggybacking on the distribution networks of established food manufacturers.

What is Missing from the Enough Deck

The most glaring omission is a detailed financial slide. While they mention being the 'lowest cost producer,' they do not provide unit economics, COGS (Cost of Goods Sold), or projected margins. For a Series B 'Growth Round,' investors typically expect to see a clear path to profitability or at least a detailed breakdown of how the cost per kilogram scales as production volume increases. Additionally, there is no mention of existing B2B contracts or a sales pipeline. While they mention 'achieving revenue' on Slide 3, they don't name any partners or disclose the volume of current off-take agreements. Finally, the lack of a specific 'Ask' or 'Use of Funds' on Slide 15 makes the deck feel more like a corporate brochure than a targeted fundraising tool.

Founder Takeaways

1. Contextualize your metrics: Enough doesn't just say '60,000 tonnes'; they say '30 cows per hour.' If your product involves high-volume production, find a relatable comparison that sticks in the investor's mind. 2. Lead with your moat: For Enough, the moat isn't just a recipe; it's the 'World’s largest new protein facility.' If you have physical assets or proprietary infrastructure, make them the star of the show. 3. Use 'Bearish' data to your advantage: By showing that you can win even in a conservative market scenario, you build trust. Enough’s use of UBS estimates (Slide 7) shows they aren't just drinking their own Kool-Aid. 4. The Team is more than just founders: Enough highlighted their Board and NXD (Non-Executive Directors) prominently. For a capital-intensive business, showing that you have 'adults in the room' with deep industry experience (like the former BP CEO) is vital for securing large checks.